These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25163347)

  • 1. [Recombinant allergens for diagnosis and specific immunotherapy--value in pediatric patients].
    Couderc R; Just J
    Bull Acad Natl Med; 2013 Mar; 197(3):645-59; discussion 659-60. PubMed ID: 25163347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interests of recombinant allergens in the practice of allergy].
    Karoui O; Leimgruber A; Spertini F
    Rev Med Suisse; 2013 Jan; 9(368):22-7. PubMed ID: 23367699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant allergens for diagnosis and therapy of allergic disease.
    Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
    J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
    Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
    Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Natural allergens and recombinant allergens].
    Deviller P
    Allerg Immunol (Paris); 1995 Nov; 27(9):316-9. PubMed ID: 8590581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant allergens: diagnostic use and therapeutic perspectives].
    Pauli G; Deviller P
    Rev Mal Respir; 2000 Feb; 17(1 Pt 2):293-303. PubMed ID: 10902143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design of allergy vaccines.
    Linhart B; Valenta R
    Curr Opin Immunol; 2005 Dec; 17(6):646-55. PubMed ID: 16229996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facing Hymenoptera Venom Allergy: From Natural to Recombinant Allergens.
    Perez-Riverol A; Justo-Jacomini DL; Zollner Rde L; Brochetto-Braga MR
    Toxins (Basel); 2015 Jul; 7(7):2551-70. PubMed ID: 26184309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant allergens for immunotherapy.
    Chapman MD; Smith AM; Vailes LD; Pomés A
    Allergy Asthma Proc; 2002; 23(1):5-8. PubMed ID: 11894735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
    Tscheppe A; Breiteneder H
    Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular-allergological aspects of allergen-specific immunotherapy].
    Jappe U
    Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant allergens for immunotherapy.
    Valenta R; Niederberger V
    J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
    Mutschlechner S; Deifl S; Bohle B
    Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.